Twenty-year employee rose through finance and leadership positions to become hospital’s first female chief executive.
A UW Medicine coronavirus scientist and two computational biologists at Fred Hutch are joining the HHMI research community.
The new CEO has served in clinical and administrative roles in her 24 years with Harborview Medical Center.
The study will test the safety and tolerability of different doses and whether they elicit an immune response.
The research also found distinct microbial signatures distinguishing patients with polyps from those without polyps.
Study findings identify witness recognition of the victim as the first in a series of actions that lead to better-than-usual survival.
This is the Center for Dialysis Innovation’s third award in the ongoing international KidneyX competition.
UW Medicine will lead a $21 million national trial of a novel vaccine aimed to reduce the effects of cytomegalovirus in liver transplants.
The device, which draws blood from capillaries in the skin, could someday replace standard blood draws for a variety of tests.
Fischer shared the 1992 Nobel Prize in Physiology or Medicine with UW School of Medicine colleague Edwin Krebs for discovering a fundamental biological switch in cells.